Critical role of farnesoid X receptor for hepatocellular carcinoma cell proliferation

Journal of Biochemistry

Volumn 152, Issue 6, 2012, Pages 577-586

  Fujino, Tomofumi ^a   Takeuchi, Airi ^a   Maruko Ohtake, Akiko ^b   Ohtake, Yosuke ^b   Satoh, Junichi ^a   Kobayashi, Tomonori ^b   Tanaka, Toshiaki ^c   Ito, Haruka ^a,d   Sakamaki, Ryosuke ^a   Kashimura, Ryo ^a   Ando, Ken ^a   Nishimaki Mogami, Tomoko ^d   Ohkubo, Yasuhito ^b   Kitamura, Naomi ^c   Sato, Ryuichiro ^e   Kikugawa, Kiyomi ^a   Hayakawa, Makio ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^d NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

cell proliferation; cyclin dependent kinase; extracellular signal regulated kinase; farnesoid X receptor; hepatocellular carcinoma cell

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE; DNA; FARNESOID X RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P16; RAS PROTEIN; RECOMBINANT SCATTER FACTOR; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE ARREST; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER REGENERATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

BUTADIENES; CARCINOMA, HEPATOCELLULAR; CELL NUCLEUS SHAPE; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HEP G2 CELLS; HEPATOCYTE GROWTH FACTOR; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; LIVER NEOPLASMS; MAP KINASE SIGNALING SYSTEM; NITRILES; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, SMALL INTERFERING;

EID: 84870888675     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvs101     Document Type: Article

References (31)

1. Carlberg, C. and Seuter, S. (2010) Dynamics of nuclear receptor target gene regulation. Chromosoma 119, 479-484
2. Forman, B.M., Goode, E., Chen, J., Oro, A.E., Bradley, D.J., Perlmann, T., Noonan, D.J., Burka, L.T., McMorris, T., Lamph, W.W., Evans, R.M., and Weinberger, C. (1995) Identification of a nuclear receptor that is activated by farnesol metabolites. Cell 81, 687-693
3. Makishima, M., Okamoto, A.Y., Repa, J.J., Tu, H., Learned, R.M., Luk, A., Hull, M.V., Lustig, K.D., Mangelsdorf, D.J., and Shan, B. (1999) Identification of a nuclear receptor for bile acids. Science 284, 1362-1365
4. Parks, D.J., Blanchard, S.G., Bledsoe, R.K., Chandra, G., Consler, T.G., Kliewer, S.A., Stimmel, J.B., Willson, T.M., Zavacki, A.M., Moore, D.D., and Lehmann, J.M. (1999) Bile acids: natural ligands for an orphan nuclear receptor. Science 284, 1365-1368
5. Wang, H., Chen, J., Hollister, K., Sowers, L.C., and Forman, B.M. (1999) Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol. Cell. 3, 543-553
6. Seol, W., Choi, H.S., and Moore, D.D. (1995) Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors. Mol. Endocrinol. 9, 72-85
7. Glass, C.K. (1994) Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr. Rev. 15, 391-407
8. Huber, R.M., Murphy, K., Miao, B., Link, J.R., Cunningham, M.R., Rupar, M.J., Gunyuzlu, P.L., Haws, T.F., Kassam, A., Powell, F., Hollis, G.F., Young, P.R., Mukherjee, R., and Burn, T.C. (2002) Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. Gene 290, 35-43
9. Zhang, Y., Kast-Woelbern, H.R., and Edwards, P.A. (2003) Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation. J. Biol. Chem. 278, 104-110
10. Rizzo, G., Disante, M., Mencarelli, A., Renga, B., Gioiello, A., Pellicciari, R., and Fiorucci, S. (2006) The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo. Mol. Pharmacol. 70, 1164-1173
11. Cariou, B., van Harmelen, K., Duran-Sandoval, D., van Dijk, T.H., Grefhorst, A., Abdelkarim, M., Caron, S., Torpier, G., Fruchart, J.C., Gonzalez, F.J., Kuipers, F., and Staels, B. (2006) The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice. J. Biol. Chem. 281, 11039-11049
12. Fiorucci, S., Rizzo, G., Donini, A., Distrutti, E., and Santucci, L. (2007) Targeting farnesoid X receptor for liver and metabolic disorders. Trends Mol. Med. 13, 298-309
13. Zhang, Y. and Edwards, P.A. (2008) FXR signaling in metabolic disease. FEBS Lett. 582, 10-18
14. Huang, W., Ma, K., Zhang, J., Qatanani, M., Cuvillier, J., Liu, J., Dong, B., Huang, X., and Moore, D.D. (2006) Nuclear receptor-dependent bile acid signaling is required for normal liver regeneration. Science 312, 233-236
15. Han, J., Tsukada, Y., Hara, E., Kitamura, N., and Tanaka, T. (2005) Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells. J. Biol. Chem. 280, 31548-31556
16. Tsukada, Y., Miyazawa, K., and Kitamura, N. (2001) High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2. J. Biol. Chem. 276, 40968-40976
17. Zhang, Y., Castellani, L.W., Sinl, C.J., Gonzalez, F.J., and Edwards, P.A. (2004) Peroxisome proliferatoractivated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev. 18, 157-169
18. Sirvent, A., Verhoeven, A.J., Jansen, H., Kosykh, V., Darteil, R.J., Hum, D.W., Fruchart, J.C., and Staels, B. (2004) Farnesoid X receptor represses hepatic lipase gene expression. J. Lipid Res. 45, 2110-2115
19. Lew, J.L., Zhao, A., Yu, J., Huang, L., De Pedro, N., Peláez, F., Wright, S.D., and Cui, J. (2004) The farnesoid X receptor controls gene expression in a ligand-and promoter-selective fashion. J. Biol. Chem. 279, 8856-8861
20. Takagi, S., Nakajima, M., Kida, K., Yamaura, Y., Fukami, T., and Yokoi, T. (2010) MicroRNAs regulates human hepatocyte nuclear factor 4 alpha, modulating the expression of metabolic enzymes and cell cycle. J. Biol. Chem. 285, 4415-4422
21. Junttila, M.R., Li, S.P., and Westermarck, J. (2008) Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J. 22, 954-965
22. Kondo, A., Hirayama, N., Sugito, Y., Shono, M., Tanaka, T., and Kitamura, N. (2008) Coupling of Grb1 to Gab1 mediates hepatocyte growth factorinduced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation. J. Biol. Chem. 283, 1428-1436
23. Zhang, Y., Gong, W., Dai, S., Huang, G., Shen, X., Gao, M., Xu, Z., Zeng, Y., and He, F. (2012) Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells. Mol. Cancer Res. 10, 516-522
24. Ushio, K., Hashimoto, T., Kitamura, N., and Tanaka, T. (2009) Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16/INK4a in hepatoma cells. Mol. Cancer Res. 7, 1179-1188
25. Yang, Y., Zhang, M., Eggertsen, G., and Chiang, J.Y. (2002) On the mechanism of bile acid inhibition of rat sterol 12alpha-hydroxylase gene (CYP8B1) transcription: roles of alpha-fetoprotein transcription factor and hepatocyte nuclear factor 4alpha. Biochim. Biophys. Acta. 1583, 63-73
26. Klein, K., Kullak-Ublick, G.A., Wagner, M., Trauner, M., and Eloranta, J.J. (2009) Hepatocyte nuclear factor-4alpha and bile acids regulate human concentrative nucleoside transporter-1 gene expression. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G936-G947
27. Hirokane, H., Nakahara, M., Tachibana, S., Shimizu, M., and Sato, R. (2004) Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4. J. Biol. Chem. 279, 45685-45692
28. Chen, W.D., Wang, Y.D., Zhang, L., Shiah, S., Wang, M., Yang, F., Yu, D., Forman, B.M., and Huang, W. (2010) Farnesoid X receptor alleviates age-related proliferation defects in regenerating mouse livers by activating forkhead box m1b transcription. Hepatology 51, 953-962
29. Wang, X., Kiyokawa, H., Dennewitz, M.B., and Costa, R.H. (2002) The Forkhead Box m1b transcription factor is essential for hepatocyte DNA replication and mitosis during mouse liver regeneration. Proc. Natl Acad. Sci. USA. 99, 16881-16886
30. Fujino, T., Murakami, K., Ozawa, I., Minegishi, Y., Kashimura, R., Akita, T., Saitou, S., Atsumi, T., Sato, T., Ando, K., Hara, S., Kikugawa, K., and Hayakawa, M. (2009) Hypoxia downregulates farnesoid X receptor via a hypoxia-inducible factor-independent but p38 mitogen-activated protein kinase-dependent pathway. FEBS J. 276, 1319-1332
31. Borude, P., Edwards, G., Walesky, C., Li, F., Ma, X., Kong, B., Guo, G.L., and Apte, U. (2012) Hepatocyte specific deletion of farnesoid X receptor delays, but does not inhibit liver regeneration after partial hepatectomy in mice. Hepatology, 2012. doi:10.1002/hep.25918. [Epub ahead of print]